CN Patent

CN104672214B — 具有alk抑制活性的化合物及其制备与用途

Assigned to Shanghai Hansen Biological Medicine Technology Co Ltd · Expires 2019-04-12 · 7y expired

What this patent protects

本发明涉及具有ALK抑制活性的化合物及其制备与用途。具体而言，本发明涉及一种如通式(I)所示的化合物或其可药用盐，其制备方法及其用途。所述化合物具有ALK抑制活性，可用于治疗ALK呈阳性的相关癌症，具有广阔的用药前景。

USPTO Abstract

本发明涉及具有ALK抑制活性的化合物及其制备与用途。具体而言，本发明涉及一种如通式(I)所示的化合物或其可药用盐，其制备方法及其用途。所述化合物具有ALK抑制活性，可用于治疗ALK呈阳性的相关癌症，具有广阔的用药前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN104672214B
Jurisdiction
CN
Classification
—
Expires
2019-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Hansen Biological Medicine Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.